Life Science Tools Market Players:
- Agilent Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Merck KGaA
- QIAGEN N.V.
- Oxford Instruments plc
- GE HealthCare Technologies, Inc.
As life science tools are always developing and advancing technologically, there is intense competition in the global market for these tools. Furthermore, the industry participants employ cooperation, amalgamation, alliance, and additional inorganic expansion tactics to provide an extensive array of inventive and appealing resolutions to their clientele.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of life science tools is evaluated at USD 186.95 billion.
The global life science tools market size was worth over USD 168.18 billion in 2025 and is poised to witness a CAGR of around 12.4%, crossing USD 541.3 billion revenue by 2035.
North America life science tools market will hold more than 38% share by 2035, driven by adoption of proteomics, oncology, genomics, and diagnostic screening.
Key players in the market include F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Oxford Instruments plc, GE HealthCare Technologies, Inc., Becton, Dickinson and Company, Shimadzu Corporation.
